Revolution Medicines Stock Forecast

Stock Price Forecast

The 17 analysts that cover Revolution Medicines stock have a consensus rating of "Strong Buy" and an average price target of $77.47, which forecasts a 0.95% increase in the stock price over the next year. The lowest target is $64 and the highest is $99.

Price Target: $77.47 (+0.95%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$64	$77.47	$75	$99
Change	-16.60%	+0.95%	-2.27%	+29.01%

* Price targets were last updated on Nov 18, 2025.

Analyst Ratings

The average analyst rating for Revolution Medicines stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	8	7	9	10	9	9
Buy	5	6	7	6	9	8
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	13	16	16	18	17

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Kalpit Patel Wolfe Research	Wolfe Research	Buy Initiates $75	Buy	Initiates	$75	-2.27%	Nov 18, 2025
Brian Cheng JP Morgan	JP Morgan	Buy Maintains $71 → $82	Buy	Maintains	$71 → $82	+6.85%	Nov 6, 2025
Robert Driscoll Wedbush	Wedbush	Buy Maintains $77 → $80	Buy	Maintains	$77 → $80	+4.25%	Nov 6, 2025
Ami Fadia Needham	Needham	Strong Buy Maintains $66 → $72	Strong Buy	Maintains	$66 → $72	-6.18%	Nov 6, 2025
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $72 → $73	Strong Buy	Maintains	$72 → $73	-4.87%	Nov 6, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

4.22M

Revenue Next Year

34.37M

from 4.22M

714.50%

from 4.22M

EPS This Year

-5.71

from -3.58

EPS Next Year

-6.54

from -5.71

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	42.98M	29.39M	35.38M	11.58M	-	4.22M	34.37M
Revenue Growth	-14.10%	-31.62%	20.38%	-67.27%	-	-	714.50%
EPS	-2.01	-2.57	-3.08	-3.86	-3.58	-5.71	-6.54
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	23	23

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	43.8M	191.8M
Avg	4.2M	34.4M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026
High	-	4,446.0%
Avg	-	714.5%
Low	-	-

EPS Forecast

EPS	2025	2026
High	-5.19	-4.71
Avg	-5.71	-6.54
Low	-5.64	-7.48

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.